Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Ori SegalMichael MimouniGilad RabinaRoy YavnieliArie Y NemetPublished in: International ophthalmology (2020)
In patients with ischemic CRVO treated with bevacizumab, BCVA improvement at 1 year can be partially predicted from baseline OCT measurements by the extent of COST, OPL and EZ disruption.